Health Care/Hospital
Imaging Endpoints Unveils New Initiative with Revolution Endpoints™, an Investment Subsidiary to Accelerate Innovation and Growth
SCOTTSDALE, Ariz., May 7, 2024 /PRNewswire/ -- Imaging Endpoints (IE), a global leader in Imaging CRO technologies and services, has announced the formation of a new subsidiary, Revolution Endpoints, focused on leveraging the Company's strong leadership and financial position to acquire synergist...
2024-05-07 21:00
863
Mr. Kong, Nano Labs' Chairman and CEO, Increased His Shareholding in the Company
HANGZHOU, China , May 7, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider inChina, announced today that Mr. Jianping Kong, the Company's chairman and chief executive officer, inf...
2024-05-07 21:00
1197
Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for Ecnoglutide Injection (XW003) in South Korea
HANGZHOU, China and SEOUL, South Korea, May 7, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation, a South Korean commercial stage pharmaceutical company (KOSDAQ: 195940),...
2024-05-07 15:00
882
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis LONDON, May 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intellig...
2024-05-07 15:00
827
2024 World Brain Day Dedicated to Brain Health and Prevention
LONDON, May 7, 2024 /PRNewswire/ -- The World Federation of Neurology (WFN) is pleased to announce Brain Health and Prevention as the theme for the 2024 World Brain Day (WBD 2024), taking place onMonday, July 22. The goal is to raise critical awareness to prevent brain disease in all corners of t...
2024-05-07 14:45
364
GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024
YONGIN, South Korea, May 7, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual ...
2024-05-07 13:27
911
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343（Anti-Claudin18.2 ADC）as Monotherapy for Advanced Gastric Cancer
SAN FRANCISCO and SUZHOU, China, May 7, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...
2024-05-07 08:12
1094
HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications
JAVENÉ, France, May 6, 2024 /PRNewswire/ -- HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American company Modern Meadow (Nutley, NJ). Notably, this acquisitio...
2024-05-07 07:00
959
ThinkCyte Launches New Website and Showcases VisionSortTM at Global Events
TOKYO, May 7, 2024 /PRNewswire/ -- ThinkCyte today announced that it will be presenting at three major international scientific conferences in the first week of May and the launch of itsupdated website. The company will have a presence at the American Society for Immunology (AAI) fromMay 3rd to 7...
2024-05-06 23:25
1007
Datasea Pre-Announces Estimated Revenue of $12.5 Million for April 2024 Supporting its Prior Revenue Guidance of $86 Million for Fiscal 2024
DTSS on Track to Achieve Record Revenue for Fiscal 2024 as it Further Penetrates China's$528 Billion 5G Market BEIJING, May 6, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a digital technology company incorporated inNevada and engaged in innovative business seg...
2024-05-06 22:00
1525
German car manufacturer visits HoneyNaps, a South Korean sleep tech company, to develop new automotive healthcare applications
Monitoring biosignals for both drivers and passengers - Analyzing and diagnosing with FDA-approved algorithm SEOUL, South Korea, May 6, 2024 /PRNewswire/ -- Amid the rapid advancement in automobile healthcare and digital healthcare markets, global car manufacturers are racing to adopt cutting ed...
2024-05-06 22:00
959
21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally
* Combining world-class industrially proven technology with fermentation capacity, 21st.BIO helps customers get to scale faster, in a risk-mitigated and cost-effective way. * Margrethe Vestager, Executive Vice President of the European Commission, was onsite to inaugurate the pilot facility, ...
2024-05-06 15:53
993
Global Fitness Giant Anytime Fitness Celebrates 25-Club Milestone in Indonesia
TANGERANG, Indonesia, May 6, 2024 /PRNewswire/ -- Anytime Fitness, the world's largest fitness franchise with over 5 million members throughout 5,500 clubs across 42 countries on all seven continents, announced its milestone 25th club in the health-crazed Indonesian market. Located at the bustlin...
2024-05-06 15:49
1284
Healthplex Expo, Natural & Nutraceutical Products China 2024 to Shine in Shanghai in June
SHANGHAI, April 30, 2024 /PRNewswire/ -- "Healthplex Expo 2024, Natural & Nutraceutical Products China 2024" (HNC), co-organized by CCCMHPIE and Sinoexpo Informa Markets, will be held during19-21 June 2024 at the National Exhibition and Convention Center (NECC)in Shanghai. HNC expo will be co-loc...
2024-05-06 13:29
1246
Dr. Sarah Salvilla to lead new FWD HealthyMe business
HONG KONG, May 6, 2024 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group"
or "FWD") today announced the appointment of Dr.Sarah Salvilla as Group Chief
Health Officer to lead a new health business unit, FWD HealthyMe.
2024-05-06 11:17
1180
Alphamab Oncology to Present Chinese Clinical Data of JSKN003 for the Treatment of HER2-expressing Solid Tumors for the First Time at the 2024 ASCO Annual Meeting
SUZHOU, China, May 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that data from the clinical study conducted inChina (JSKN003-102) of anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 for the treatment of HER2-expressing advanced solid tumors, will be presente...
2024-05-06 10:25
1897
Palm Oil Giant Musim Mas Pledges Third Tranche of S$5 million In Boost to Local Charities
Latest donation makes it S$16 million in 5 years as the Singapore-based company reaffirms commitment to improving lives SINGAPORE, May 6, 2024 /PRNewswire/ -- Palm oil giant Musim Mas Group has announced its latestS$5 million donation to selected local charities. This brings the group's total do...
2024-05-06 09:00
1247
H2:iD HYDROGEN WATER ON THE GO™ PRESENTS GROUNDBREAKING APPROACH TO WELLNESS WITH NATURAL ENERGY BOOST
* H2:iD delivers 1,200% more parts per million (PPM) of Hydrogen Gas compared to conventional alternatives. * Hydrogen Water offers a calm energy boost, unlike caffeine, with a study revealing its nuanced impact on alertness compared to caffeine in sleep-deprived individuals. SINGAPORE, May 6...
2024-05-06 09:00
1201
World Lupus Federation Global Survey Finds 91% of People with Lupus Report Using Oral Steroids to Treat Lupus
Global public urged to share survey results and lupus facts on May 10 for World Lupus Day WASHINGTON, May 6, 2024 /PRNewswire/ -- A recent global survey conducted by the World Lupus Federation reported that 91% of survey respondents were taking or have taken oral steroids to treat their lupus. O...
2024-05-06 08:00
1101
VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure
* VYNDAMAX has been listed on the Pharmaceutical Benefits Scheme (PBS) for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM)with New York Heart Association (NYHA) Class I-II heart failure.[1] * ATTR-CM is a debilitating and often fatal condition that l...
2024-05-04 18:00
2205
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 317 media titles]
2024-05-07 08:00
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 312 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 306 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 290 media titles]
2024-05-08 16:44
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
14378
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
9999
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9532
